Surgery Partners

Forecast & Rating12 analysts currently cover Surgery Partners, with about 75.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $18.73, about 34.1% upside from the current price of $13.96. Price targets range from $14.00 to $24.00 — a wide spread, showing clear disagreement over just how much Surgery Partners can rise. Historically, about 34.6% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Surgery Partners closely still see room for the stock to rise. Data as of Aug 28, 2026; for reference only and not investment advice.